
Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…
Track Nifty as Trump’s tariff threats shake its recovery, pharma rallies, and metals falter – see how markets may move…
Investors are increasingly turning to ‘safer’ MNC pharma stocks with a domestic focus at a time when the Trump administration…
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…
IEX surges 11% after market jitters; Cipla posts strong Q1, while APL Apollo falls on missed guidance. Track the latest…
Cipla reports 10 per cent rise in net profit to Rs 1,298 crore for Q1FY26 with India business crossing Rs…
Markets remain cautious ahead of earnings; track Tata Steel, JSW Steel, and Cipla for breakout moves this week.
Torrent Pharma will emerge among the top 5 domestic pharma players by sales with the acquisition of J B Chemicals…
Cipla aims for FY26 growth via inorganic expansion and new product launches, especially 2-3 peptide assets. Its FY25 report highlights…
Stay updated as 33 companies, including HDFC Bank and HUL, announce dividends, stock splits, and bonuses this week – check…
Cipla share price today, May 15: Nuvama retains ‘Hold’ on Cipla at Rs 1,620 target; watch for future product launches…
Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to grow…
Drug major Cipla on Tuesday said its consolidated net profit increased 30 per cent to Rs 1,222 crore in the…
The pharma stocks in India see significant selloff after US President Donald Trump signs executive orders promoting active and faster…
Maruti and Cipla trade below long-term P/E averages. Both show solid fundamentals, but growth has slowed. Execution on new launches…
Nomura recommends Buy for Dr. Reddy’s, Cipla, Lupin, Zydus amid pharma stock pressure. Check latest market trends!
Pharma stocks drop as Trump announces major tariffs on imports. Explore market impact!
Pharma stocks surge as Trump’s tariff exemption boosts sector morale. Dive into this bullish trend today!